We used intracellular microelectrodes to study the effect of changes in extracellular calcium ion concentration [Ca 2+ ] o on the transmembrane potentials of canine cardiac Purkinje fibers in control Tyrode's solution and in the presence of agents thought to modify membrane permeability to potassium. In Tyrode's solution, decreasing [Ca 2+ ] o from 2.7 to 0.9 mM increased action potential duration measured at -60 mv (APD «,) and at full repolarization (APDioo) but did not significantly modify the normal linear relationship between cycle length and APD between cycle lengths of 500 to 4000 msec. We used 9-aminoacridine (9-AA) to decrease potassium permeability. At concentrations between 0.01 and 1.5 x 10" 5 M, 9-AA caused a concentration-dependent increase in APD-M and APD 1O o and a significant increase in the slope of the line relating APD to cycle length. The usual effects of changes in [Ca z+ ] o on APD were potentiated by 9-AA. We then used lidocaine (L) to increase potassium permeability. At concentrations between 0.75 and 1.5 x 10~5 M, L significantly increased the slope of the line relating APD and cycle length. In the presence of L an increase in [Ca 2+ ] o increased both APD_eo and APD,oo, and a decrease in [Ca 2+ ] o decreased both parameters. 9-AA thus potentiated and L reversed the effects of changing [Ca 2+ ] o on APD. The results suggest that changes in [Ca 2+ ] o modify repolarization by modifying both slow inward current and potassium permeability and that the extent to which the latter changes can determine the effect of [Ca 2+ ] o on APD.
IT HAS BEEN known for many years that changes in the extracellular concentration of calcium ions [Ca 2+ ] o modify repolarization of ventricular muscle (Schiitz, 1936; Cranefield and Hoffman, 1958; Surawicz et al., 1959) and that substitution of other divalent cations such as Sr 2+ for Ca 2+ delays repolarization (Brooks et al., 1955; Garb, 1951) . After intracellular microelectrodes were introduced to the study of cardiac electrophysiology, it was shown in most studies that a decrease in [Ca 2+ ] o prolonged and an increase in [Ca 2+ ] o shortened the transmembrane action potential of both ventricular muscle fibers (Hoffman and Suckling, 1956) and Purkinje fibers (Hoffman and Suckling, 1956; Weidmann, 1955) . Somewhat similar relationships between [Ca 2+ ] o and action potential duration were found for atrial muscle fibers (Hoffman and Suckling, 1956; Hoffman and Cranefield, 1960) . For Purkinje fibers, in addition to influencing action potential duration, changes in [Ca 2+ ] o had important effects on threshold potential, on the voltage-dependence of activation of the fast inward channel (gNa) (Weidmann, 1955) , and on phase 4 depolarization and automaticity (Hoffman and Suckling, 1956; Weid-mann, 1955; Hoffman and Cranefield, 1960; Temte and Davis, 1967) . Also, although changes in [Ca 2+ ] o did not influence membrane resistance (Weidmann, 1955) , they did alter the relationship between extracellular potassium concentration [K + ] o and resting potential (Hoffman and Cranefield, 1960) . Finally, a number of studies have shown for fibers from sheep and calf hearts that an increase in [Ca 2+ ] o shifts the plateau to more positive potentials and a decrease has the opposite effect (Reuter and Scholz, 1976; Beeler and Reuter, 1970) .
These effects of [Ca 2+ ] o on action potential duration and on the voltage level of the plateau were difficult to explain in terms of the finding for both Purkinje fibers and ventricular muscle that a significant inward current is carried by Ca 2+ through the secondary or slow inward channels (g si ) and that this current is responsible in large part for maintaining the membrane potential at depolarized levels after the initial action potential upstroke. In terms of these findings one would expect an increase in [Ca 2+ ] o to delay repolarization by increasing inward current and a decrease to have the opposite effect because of the change in driving force for Ca 2+ . An increase in action potential duration in the presence of high [Ca 2+ ] o has been seen only at quite low rates of stimulation (Niedergerke and Orkand, 1972) ; at usual rates of activation the opposite effect is observed. This apparently anomalous effect of Ca 2+ on action potential duration has been explained by assuming that changes in [Ca 2+ ] o result in changes in [Ca 2+ ]i and that the latter influences the conductance of the membrane VOL. 46, No. 2, FEBRUARY 1980 to potassium. Such a relationship has been demonstrated for other types of cells (Meech, 1972; Clusin et al., 1974) . With respect to the heart, it has been shown that intracellular injection of Ca 2+ hyperpolarizes and shortens the action potential of Purkinje fibers (Isenberg, 1975) and that increases in [Ca 2+ ]i markedly increase potassium conductance of ventricular muscle fibers (Bassingthwaighte et al., 1976) . Recently, the effects of changes in [Ca 2+ ] o on potassium conductance have been modelled for Purkinje (Kass and Tsien, 1976) and ventricular muscle fibers (Beeler and Reuter, 1977) .
Because most of the data explaining the effects of changes in [Ca 2+ ] o on action potential duration have been obtained by use of voltage-clamp techniques, we thought it might be of use to examine the question by a different method. We attempted to demonstrate both the direct effect of changing [Ca 2+ ] o (i.e., that resulting from a change in i si ) and the indirect effect (i.e., that resulting from a change in potassium conductance) by using pharmacological agents to modify potassium conductance of canine Purkinje fibers. The two agents we used to study the problem were lidocaine and 9-aminoacridine (9-AA). Lidocaine is believed to exert a number of its effects on the transmembrane potentials of Purkinje fibers by increasing potassium conductance (Bigger and Mandel, 1970; Weld and Bigger, 1976) ; 9-aminoacridine, a member of a large structural family of fluorescent dyes, decreases potassium conductance of frog skeletal muscle (Voile, 1971) . Our studies show that, after exposure to lidocaine, a higher [Ca 2+ ] o increases, and a lower [Ca 2+ ] o decreases, action potential duration. In contrast, after exposure to 9-AA, the usual effects of changes in [Ca 2+ ] o on action potential duration are potentiated.
Methods
Mongrel dogs weighing 15-30 kg were anesthetized with sodium pentobarbital, 30 mg/kg, iv. The heart was removed rapidly through a right lateral thoracotomy and placed in cool oxygenated Tyrode's solution. Bundles of Purkinje fibers (PF) occurring as false tendons in the right and left ventricle were excised and stored in Tyrode's solution gassed with 95% O 2 -5% CO 2 . One bundle was mounted in a Lucite tissue bath for microelectrode study of transmembrane potentials (Aronson et al., 1973) .
Tyrode's solution, gassed with 95% O 2 -5% CO 2 , was warmed and pumped into the tissue bath at 15 ml/min. Throughout the experiment, temperature was maintained at 37 + 0.2°C and monitored with a thermistor probe (Yellow Springs Instrument Co.) located within 3 mm of the tissue. For most experiments, the composition of the Tyrode's solution, in mM, was: NaCl, 137; NaHCO 3 , 12; NaH 2 PO 4 , 1.8; dextrose, 5.5; MgCl 2 , 0.5; KC1, 2.7; CaCl 2 , 2.7.
Driving stimuli were delivered to the tissue through Teflon-coated bipolar silver wire electrodes and were isolated from ground. Stimuli were approximately 1.5 times threshold and 1-1.5 msec in duration; for any given experiment, stimulus strength and duration were not varied once control action potentials had been recorded. For each experiment, the tissue was stimulated at several different cycle lengths (CL). Transmembrane potentials were recorded through microelectrodes filled by boiling under reduced pressure in 3 M KC1. Electrode resistance was between 10 and 30 MS2. The electrodes were coupled by a 3 M KC1 interface to a Ag-AgCl bar connected to an operational amplifier with high input impedance and input-capacity neutralization. The maximum rate of rise of phase 0 of the action potential (V max ) was measured by recording the first time derivative through an operational amplifier calibrated against a linear sawtooth pulse (Bigger et al., 1968) . 9-Aminoacridine (9-AA) (K & K Laboratories, Inc.) (mol wt = 194) was prepared in a concentrated stock solution (10 mg/ml in 40% ethanol), and aliquots were diluted and added to the Tyrode's solution to give the desired concentrations. Volumes of ethanol equivalent to those added during drug superfusion were shown to produce no discernible effects on transmembrane potentials. For experiments with lidocaine (L), we used a commercially available preparation of the hydrochloride salt (Astra Pharmaceutical Products Inc.) (mol wt = 270), 40 mg/ml. For drug superfusion, aliquots of the appropriate solution were added to Tyrode's solution prepared in a separate gassed reservoir.
Records of the transmembrane potential and V max were made with a Tektronix RM565 oscilloscope and a Polaroid camera. Transmembrane potentials were recorded both at low and high amplification to demonstrate changes in the entire action potential and in the slope of phase 4 depolarization.
All results were recorded from single impalements maintained throughout the experiment. In several cases, two impalements of different cells at least 1 cm apart were maintained in the same preparation. Thus, for different experimental sequences, both the number of experiments and the total number of continuously monitored cells are reported. Data were analyzed using Student's paired t-test. Regression lines were calculated using the method of least squares, and the regression coefficients were compared by analysis of covariance.
Results
Effects of 9-AA Figure 1 shows the results of an experiment in which the preparation was stimulated at two different cycle lengths, 1000 and 4000 msec, and superfused for 45 minutes with Tyrode's solution containing 9-AA first at 0.1 X 10" 5 M and then at 1.0 X 10~5 M. The control tracings are shown on the left. Changing from a CL of 1000 to 4000 msec caused no change in maximum diastolic potential (MDP), action amplitude, or V max . Action potential duration, measured both as the time necessary for repolarization to -60 mV (APD-oo) or for 100% repolarization (APDioo), increased on changing to the longer cycle length. The middle panel shows the transmembrane potentials of the same cell after superfusion for 45 minutes with Tyrode's solution containing 0.1 X 10" 5 M 9-AA. At a CL of 1000 there is a slight prolongation of APD-eo and APDioo that reflects a decrease in slope of phase 3. At a CL of 4000 the increases in APD-eo and APDioo are more pronounced. The contour of phase 4 depolarization is not altered appreciably. The panel on the right shows the responses of the same cell after superfusion for 45 minutes with Tyrode's solution containing 1.0 X 10" 5 M 9-AA. At both CL there is a further prolongation of APD. In this preparation there is also a slight decrease in the slope of phase 4 depolarization due primarily to a 3 mV shift of the activation voltage (AV) toward more negative potentials. Effects of 9-AA (0.01 to 1.5 x 10" 5 M) were studied in 31 experiments by monitoring a total of 60 cells at CL of 500, 1000, 2000, and 4000 msec. Steady state effects were reached after 45 minutes of superfusion with drug-containing Tyrode's solution. Effects of 9-AA were partially reversible by long periods of washout (>1M> hour) with drug-free Ty-rode's solution. Results of these experiments are shown in Figure 2 . At all but the shortest cycle lengths, APD-eo and APDioo show statistically significant and dose-dependent increases at concentrations of 9-AA that did not change the other measured parameters. At higher concentrations of 9-AA, there is a small but statistically significant decrease in overshoot, V ma x, and AP amplitude as well as a small decrease in MDP at CL = 4000 msec for 9-AA = 1.5 X 10" 5 M. Except at the highest concentration examined, there was no statistically significant change in the slope of phase 4 depolarization; at 9-AA = 1.5 x 10~5 M the slope decreased from 1.38 ± 0.30 mV/sec to 0.64 ± 0.35 mV/sec (P < 0.05). Superfusion with higher concentrations of 9-AA (5.0 X 10' 5 M to 1.0 x 10~4 M) caused a significant decrease in MDP (10-30 mV) and eventually lead to inexcitability.
Effects of 9-AA on the Rate Dependence of APD
In normal Tyrode's solution, APDioo increases by approximately 32% as CL increases from 500 to 4000 msec and APD-eo increases by 38%. Figure 3 shows plots of cycle length vs. AP duration for APD-60 (panel A) and APDioo (panel B) under control conditions and during superfusion with several concentrations of 9-AA. Least square best fits are plotted for 9-AA = 0.1, 1.0, and 1.5 X 10" 5 M, with indicated regression coefficients and the statistical significance of the difference in slope between control conditions and during superfusion with 9-AA. This analysis suggests that higher concentrations of 9-AA significantly modify the rate dependence of action potential duration. Figure 4 shows the results of an experiment in which a preparation stimulated at a CL of 1000 and 4000 msec was superfused with Tyrode's solution containing one-third the control concentration of calcium. The panel on the left shows the control tracings. Superfusion for 20 minutes with Tyrode's solution containing 0.9 mM Ca 2+ (right panel) leads to an increase in APD-60 and APDioo at both cycle lengths. Effects of a decrease in [Ca 2+ ] o on APD are summarized in Table 1A . The increases in APD-eo and APDioo when [Ca 2+ ] o is decreased appear to result from a decrease in the slope of phase 2, rather than from a change in the slope of phase 3, as was the case during superfusion with 9-AA ( Fig. 2) . A slight decrease in activation voltage also is seen at both CL. Figure 5 shows plots of cycle length vs. AP duration (APD-60 and APDioo) for PF superfused with control Tyrode's solution in which [Ca 2+ ] o is 2.7 mM, and then with Tyrode's in which [Ca 2+ ] o is 1.35 or 0.9 mM. Least square best fits are plotted with the regression coefficients. There was no statistically significant difference among the slopes of the derived regressions. This analysis suggests that a decrease in [Ca 2+ ] o does not significantly modify 1000 and 4000 msec are shown on the left and are action potentials from the same cell as in Figure 4 , after return to Tyrode's solution with [Ca 2+ ] o = 2.7 mM. The middle panel shows the transmembrane potentials after supervision with Tyrode's containing 9-AA for 45 minutes. In addition to the increases in APD-eo and APDioo, there is a slight loss of MDP, a small decrease in V max , and a disappearance of the notch marking the transition from phase 1 to phase 2. Superfusion with Tyrode's solution containing the same concentration of 9-AA but with [Ca 2+ ] o reduced to 0.9 mM leads to greater increases in APD-eo and APD 100 , increases nearly twice those Figure 4 . In superfusate with [Ca 2+ ] o = 0.9 mM, 9-AA increases APD ,oo by 32% at a cycle length of 1000 and by 34% at a cycle length of 4000 msec.
Effects of Decreased [Ca 2+ ] o on APD
shown by the same cell when [Ca 2+ ] o was lowered to 0.9 mM in the absence of 9-AA ( Fig. 4) . We investigated the effects on the action potential of decreasing [Ca 2+ ] o in the presence of 1.0 X 10~5 M in 9-AA in eight experiments. Effects on APD-eo and APDioo are summarized ; n Table IB . At a CL of 1000 msec, MDP and activation voltage decreased slightly in several experiments but these changes did not attain statistical significance. There also were small but significant decreases in AP amplitude and overshoot. In contrast, APD-60 and APDioo increased dramatically at both cycle lengths when [Ca 2+ ] o was decreased. At a CL of 4000 msec the changes in APD were of similar magnitude and, also, slight but significant decreases in MDP and activation voltage were recorded. Changes in APD caused by a decrease in [Ca 2+ ] o in control Tyrode's were studied in 12 experiments (Table 1A .) As suggested by the example illustrated ( Fig. 4) at CL of 1000 and 4000 msec, in the absence of 9-AA comparable decreases in [Ca 2+ ] o produced significantly smaller changes in APD-60 and APDioo.
Effects of Increased [Ca 2+ J o on APD
For these experiments the concentration of 9-AA was 1.5 X 10~5 M, one which maximally increased APD. The results of 11 experiments at CL of 500, 1000, and 2000 msec are presented in Table 2 . The decrease in APD caused by increased [Ca 2+ ] o is statistically significant for both values of increased [Ca 2+ ] o at all three CL. In a study of canine PF in normal Tyrode's solution and stimulated at a CL of 630 msec, Temte and Davis (1967) noted decreases in APD-eo and APDioo of -7.4% and -3.9% on changing [Ca 2+ ] o from 2.7 to 5.4 mM and decreases of -10.8% and -6.7% when [Ca 2+ ] o was increased from 2.7 to 10.8 mM. On comparing these data with ours (Table 2 ), it appears that the degree to which an increased [Ca 2+ ] o shortens APD-eo and APDioo is augmented in the presence of 9-AA Figure 7 shows the result of an experiment in which a preparation, stimulated at CL of 1000 arid 4000 msec, was superfused with Tyrode's solution containing lidocaine (2 /ig/ml; 0.75 X 10~5 M). The control tracings are shown on the left. Super-fusion with Tyrode's solution containing lidocaine leads to a decrease in A P D -M and APDioo, a slight decrease in V max at CL = 1000, and a decrease in the slope of phase 4 depolarization, without significant change in MDP. This results in a shift in the activation voltage toward a more negative value at both CL. Superfusion with a higher concentration of lidocaine (4 jug/ml; 1.5 X 10~5 M) leads to a slightly greater shift in activation voltage and a more pronounced decrease in APD-eo. Data on the effects of superfusion with Tyrode's solution containing lidocaine, 4 /xg/ml (1.5 X 10~5 M), for CL of 500, 1000, 2000, and 4000 msec are shown in Table 3 and summarize the results of 10 experiments. Figure 8 shows plots of cycle length vs. APD-eo and APDioo for PF superfused with control Tyrode's solution and then with Tyrode's solution containing lidocaine, 1.5 X 10~5 M. Least square best fits are plotted and regression coefficients indicated. There are statistically significant differences between the slopes in drug-free and lidocaine-containing superfusate. This suggests that lidocaine significantly modifies the rate dependence of the APD. In A and B , each division is 20 mV, 200 V/sec, and 100 msec. C is recorded at 1/10 sweep speed and double gain to show phase 4 depolarization. Figure 9 shows the results of an experiment in which [Ca 2+ ] o was decreased in the presence of lidocaine. Rather than causing an increase in APD, as had been observed in drug-free Tyrode's solution (Table 1A) , decreasing [Ca 2+ ] o to 1.35 mM in the presence of lidocaine causes a small decrease in both APD-eo and APDioo. A further decrease in [Ca 2+ ] o to 0.9 mM causes a further decrease in APD. We observed a similar decrease in APD, on decreasing [Ca 2+ ] o , in three experiments monitoring six cells with lidocaine = 0.75 X 10~5 M, and in three experiments monitoring six cells with lidocaine = 1.50 x 10~5 M. Table 4 presents data from the experiments with lidocaine = 1.5 X 10" 5 M at CL = 1000 and 4000 msec. APD_6o decreases significantly at both cycle lengths and both decreased concentrations of [Ca 2+ ] o ; decreases in APD !O o are statistically significant at [Ca 2+ ] o = 0.9 mM.
Effects of Lidocaine

Effects of Decreased [Ca 2+ ] o on APD
Effects of Increased [Ca 2+ ] o on APD
The results of an experiment in which [Ca 2+ ] o was increased during exposure to lidocaine are shown in Figure 10 . Superfusion for 25 minutes with Tyrode's solution containing lidocaine, 4 /ig/ml (1.50 x 10" 5 M), leads to a shift in both MDP and activation voltage toward more negative values, a decrease in the slope of phase 4 depolarization, and a decrease in APD-60 and APD 100. Increasing [Ca 2+ ] o during exposure to lidocaine leads to a prolongation of phase 1 and a lower take-off potential of the plateau, an increase in the slope of phase 4 depolarization, and an increase in both APD-eo and APDioo. We observed the same increase in APD on increasing [Ca 2+ ] o in two experiments monitoring four cells with lidocaine = 2 ^g/ml (0.5 X 10" 5 M) and in six experiments monitoring 12 cells with lidocaine = 4 jug/ml (1.5 x 10" 5 M). Effects on APD of increasing [Ca 2+ ] o during exposure to lidocaine (4 Mg/ml) for CL of 1000 and 4000 msec are presented in Table 4 .
Reversal by Lidocaine of the Effects of 9-AA
In three experiments monitoring six cells, we studied the ability of lidocaine to reverse the effects of 9-AA. After superfusion with Tyrode's solution containing 1.5 X 10" 5 M 9-AA, the tissue was superfused with Tyrode's solution containing the same • P < 0.05; f P < 0.01; $ P < 0.001.
concentration of 9-AA and, in addition, lidocaine (2 /ug/ml; 0.75 X 10" 5 M). Results of these experiments, for CL = 1000 and 4000 msec, are presented in Table 5 . The addition of lidocaine caused no significant change in MDP, AV, amplitude, overshoot, V max , or slope of phase 4 depolarization. There was, however, significant shortening of both APD-eo and APD,oo.
Discussion 9-AA is a planar molecule with dimensions comparable to those of the hydrated potassium ion (4.5 x 8.5 A); it has a pK a of 9.99 and therefore exists 400-
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predominantly in the ionized form at pH = 7.4. Studies of the effects of 9-AA (1.0 -100.0 X 10" 5 M) on frog sartorius muscle (Voile, 1971; Henderson and Voile, 1972) suggest that it causes an asymmetrical blockade of K + exchange, depressing efflux significantly more than influx. It has no effect on resting Na + exchange, extrusion, or content. In chloride-containing solutions with [K + ] o < 2.5 mM, 9-AA does not alter the resting membrane potential of skeletal muscle fibers; 9-AA causes changes in K + flux comparable to those produced by 5 times greater concentrations of tetraethylammonium (Voile, 1971; Henderson and Voile, 1972) . Because of our interest in the modulation of APD by Ca 2+ and the possible effects of Ca 2+ on potassium conductance, we chose to characterize the effects of 9-AA on PF action potential parameters and to observe the effects of varying [Ca 2+ ] o on fibers pretreated with it. Since lidocaine appears to have effects on membrane potassium conductance qualitatively opposite from those of 9-AA (Weld and Bigger, 1976; Voile, 1971) , we compared responses to changes in [Ca 2+ ] o in the presence of each.
Our finding that prolongation of the action potential by decreasing [Ca 2+ ] o does not alter the rate dependence of APD is in agreement with recently reported observations (Mary-Rabine and Rosen, 1978) ; these, along with evidence from voltage clamp studies, (Kass and Tsien, 1976) have been interpreted as suggesting that calcium-dependent changes in APD are secondary to changes in timeinvariant background potassium permeability. The effects of 9-AA on transmembrane potentials of Purkinje fibers also may reflect an effect on membrane conductance to K + . However, the dose-dependent increase in APD_6o and APDioo with minimal effects on MDP, AV, or slope of phase 4 at all but the highest concentrations studied, and the significant modification in the rate dependence of APD, suggest that 9-AA may effect a time-varying dynamic current rather than a background current. If 9-AA is effecting the magnitude and kinetics of some membrane K + conductance in Purkinje fibers, as it has been shown to do in frog sartorius muscle, the potentiated effects of increasing or decreasing [Ca 2+ ] o on APD in fibers pretreated with 9-AA suggest that the control value of K + conductance modulates the magnitude of the response to changes in [Ca 2+ ] o . Although we can not rule out effects of 9-AA on the kinetics of i^, it should be noted that superfusion with 9-AA neither modified plateau voltage, as might be expected if it blocked the secondary inward channel, nor markedly influences contractility.
Our findings for the effects of lidocaine on the transmembrane potential are similar to those which have been described previously (Bigger and Mandel, 1970; Weld and Bigger, 1976; Mary-Rabine and Rosen, 1978) . Action potential shortening secondary to an increase in [Ca 2+ ] o appears to cause no change in the rate dependence of APD. To the extent that this reflects effects of Ca 2+ on background, as opposed to time-varying dynamic currents, our finding of a significant change in ratedependence of APD after superfusion with lidocaine (1.5 X 10~5 M) suggests that, unlike 9-AA, lidocaine VOL. 46, No. 2, FEBRUARY 1980 For all data, n = 6. Data expressed as mean ± SE. ' P < 0.05; f P < 0.01; $ P < 0.001. may modify APD through effects on the kinetics and/or magnitude of a time-varying dynamic conductance.
The finding that exposure to lidocaine reverses the usual effects of either increasing or decreasing [Ca 2+ ] o on APD suggests that, in a setting in which potassium conductance is increased, effects of calcium on action potential configuration are related more directly to its role as a carrier of inward transmembrane current. A recently published illustration presented in the context of studies of effects of Mn 2+ on Purkinje fibers (Hogan and Spitzer, 1975) supports this hypothesis. Elevation of [Ca 2+ ] o from 1.8 to 7.2 mM in Tyrode's solution containing 21.6 mM K + leads to marked prolongation of both APD-eo and APDioo of Purkinje fibers.
Our observation that the effects of 9-AA on APD are reversed largely by addition of lidocaine to the superfusate further suggests that the two agents may be exerting opposite effects on similar or related membrane ionic permeabilities. It is evident that they provide significantly different settings for the modulation of Purkinje fiber action potential duration by calcium.
